Showing results (1111-1120 of 2,583) with videos related to

Sort By:
Pageof 259
Molecular Oncology|November 14, 2025
Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologiesJanah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, et al.
Molecular Oncology|November 14, 2025
Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncologyMarius Ilié, Umberto Malapelle, Catherine Alix-Panabières, et al.
Molecular Oncology|October 29, 2025
The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategiesMatthias Drosten, Mariano Barbacid
Molecular Oncology|October 5, 2025
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarkerAsia Pece, Giulio Lovato, Ilaria Cela, et al.
Molecular Oncology|October 5, 2025
Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18-gene panelElisabeth Spenard, Cristina Mitric, Melanie Care, et al.
Molecular Oncology|October 23, 2019
miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastomaSrinivas Chava, C Patrick Reynolds, Anup S Pathania, et al.
Molecular Oncology|April 20, 2020
HMGB1 regulates SNAI1 during NSCLC metastasis, both directly, through transcriptional activation, and indirectly, in a RSF1-IT2-dependent mannerXiao-Jin Wu, Yuan-Yuan Chen, Wen-Wen Guo, et al.
Molecular Oncology|September 12, 2025
In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinomaLukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, et al.
Molecular Oncology|September 16, 2025
Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidineShuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, et al.
Molecular Oncology|September 21, 2025
Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolismAdrien M Vaquié, Davod R Shah, Eliane E S Brechbühl, et al.
Pageof 259